Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Trump Delays Iran Deal, Oil Jumps 2% | Wockhardt shares in focus on new drug approval | Opening Bell
Global markets remain on edge as Trump signals no rush for an Iran deal, oil prices climb above $93, and investors await RBI policy cues. FIIs continue selling while auto sales, Wockhardt, and geopolitical tensions stay in focus. Catch all the key triggers on Opening Bell.
Wockhardt prepares US commercial playbook for novel antibiotic Zaynich with Zahabiya Khorakiwala at helm
The company projects Zaynich to contribute between $1.5 billion and $2 billion per annum at its peak sales, about 40 percent of that sales would be contributed by US market alone.
Wockhardt stock soars up to 16% as US FDA clears novel antibiotic Zaynich
Zaynich is designed to treat complicated urinary tract infections, including pyelonephritis, and targets infections caused by drug-resistant Gram-negative bacteria.
Stocks to Watch Today: Physicswallah, Swiggy, Q-Line Biotech, Lupin, Wockhardt, Ashok Leyland, GMR Airports, PG Electroplast, West Coast Paper in focus on 29 May
Stocks in News, 29 May: Stocks like Physicswallah, Ashok Leyland, Deepak Fertilisers & Petrochemicals Corporation, Bata India, PC Jeweller, GMR Airports, PG Electroplast, Gabriel India, Hikal, Varroc Engineering, Enviro Infra Engineers, HG Infra Engineering, Swiggy, and Indoco Remedies will be in focus on May 29.
With Wockhardt securing USFDA nod for Zaynich, focus shifts from lab to market
After decades of sustained investment in antibiotic research, Wockhardt has secured approvals for its breakthrough drug Zaynich. The challenge now is converting scientific success into commercial returns.
Wockhardt swings to profit in FY26 fuelled by biotech, emerging markets recovery
For the full year, Wockhardt reported profit after tax of Rs 199 crore, compared with a loss of Rs 57 crore in FY25, marking its first full-year profit in recent years.
Wockhardt’s Zaynich: The science behind the superbug killer, its business potential
Zaynich’s potential to address one of modern medicine’s most pressing challenges — drug-resistant ‘superbugs’ — has investors and the company excited
Momentum Stocks: Elgi Equipments, Wockhardt, Triveni Turbine, Adani Total Gas hit 52-week high
Hitech Corporation, Venus Remedies, Aditya Infotech were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.
How Wockhardt reversed years of losses in FY26, became leaner, innovation driven
The company spent years divesting assets to pay down creditors and restructure its operations:
Wockhardt stock rallies post-CDSCO nod for novel antibiotic
Wockhardt opened strong on Friday at Rs.1,716.00, and hit an intraday high of Rs.1,789, marking a sharp single-day gain of up to 5.22 percent.